Central Nervous System Agents in Medicinal Chemistry
Title:Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1)
Volume: 15 Issue: 2
Author(s): Gian L. Mariottini
Affiliation:
Export Options
About this article
Cite this article as:
Mariottini L. Gian, Editorial (Thematic Issue: The Activity of Products from Cnidaria: A Therapeutic Tool in Neurological Diseases - Part 1), Central Nervous System Agents in Medicinal Chemistry 2015; 15 (2) . https://dx.doi.org/10.2174/187152491502150525114900
DOI https://dx.doi.org/10.2174/187152491502150525114900 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
Article Metrics
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Current Neuropharmacology Negative Affect and Drinking Drivers: A Review and Conceptual Model Linking Dissonance, Efficacy and Negative Affect to Risk and Motivation for Change
Current Drug Abuse Reviews Acetylcholine Receptors and Tau Phosphorylation
Current Molecular Medicine Amyloid β Accumulation Assessed with <sup>11</sup>C-Pittsburgh Compound B PET and Postmortem Neuropathology
Current Alzheimer Research The Impending Renaissance in Discovery & Development of Natural Products
Current Topics in Medicinal Chemistry Polymorphism of the Cysteine Protease YopT from Yersinia pestis
Protein & Peptide Letters Centralized and Local Color Doppler Ultrasound Reading Agreement for Diagnosis of the Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
Current Neurovascular Research Future Approaches for Treating Hematologic Disease
Current Pharmaceutical Biotechnology Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimers Disease
Current Pharmaceutical Design Neonatal Environment and Neuroendocrine Programming of the Peripheral Respiratory Control System
Current Pediatric Reviews Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting α-Secretase as an Alternative Drug Target for Treatment of Alzheimers Disease
Current Medicinal Chemistry Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the α7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia
Central Nervous System Agents in Medicinal Chemistry The Use of Intravenous Aminobisphosphonates for the Treatment of Pagets Disease of Bone
Mini-Reviews in Medicinal Chemistry COMMENTARY: Magnetic Resonance Techniques Applied to Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Perioperative Considerations in Rheumatoid Arthritis Patients
Current Rheumatology Reviews Stem Cell and Gene Therapeutic Strategies for the Treatment of Multiple Sclerosis
Current Molecular Medicine Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands
Current Neuropharmacology γ-Secretase as a Target for Alzheimers Disease
Current Topics in Medicinal Chemistry Progress in Detection of Insomnia Sleep Disorder: A Comprehensive Review
Current Drug Targets